Table 2.
Hematological parameters of different patient groups presented as mean ± SD
| RBC (×106/μL) | Hgb (g/dL) | MCV (fL) | Ret (×106/μL) | IRF | MRV (fL) | MSCV (fL) | HLR (×106/μL) | |
|---|---|---|---|---|---|---|---|---|
| HS | 3.42 ± 0.95 | 8.88 ± 1.69 | 80.4 ± 7.78 | 0.27 ± 0.12 | 0.41 ± 0.09 | 81.79 ± 6.58 | 66.71 ± 8.45 | 0.09 ± 0.09 |
| IDA | 4.61 ± 0.38 | 10.46 ± 1.41 | 73.53 ± 7.96 | 0.05 ± 0.03 | 0.28 ± 0.07 | 97.97 ± 6.48 | 76.74 ± 6.48 | 0.03 ± 0.04 |
| IQA | 3.15 ± 0.58 | 9.41 ± 1.13 | 92.47 ± 7.94 | 0.10 ± 0.04 | 0.44 ± 0.08 | 111.73 ± 8.14 | 94.01 ± 8.50 | 0.04 ± 0.03 |
| HA | 3.35 ± 0.64 | 10.16 ± 1.69 | 93.25 ± 11.57 | 0.17 ± 0.17 | 0.43 ± 0.12 | 114.31 ± 21.14 | 91.80 ± 13.31 | 0.06 ± 0.11 |
| TM | 5.49 ± 0.43 | 11.87 ± 0.97 | 69.24 ± 4.46 | 0.07 ± 0.03 | 0.27 ± 0.06 | 90.2 ± 4.57 | 72.95 ± 4.33 | 0.03 ± 0.03 |
| CKD | 3.90 ± 0.61 | 11.29 ± 1.30 | 88.84 ± 4.78 | 0.07 ± 0.03 | 0.32 ± 0.06 | 108.56 ± 9.80 | 85.64 ± 5.48 | 0.04 ± 0.03 |
| Other | 3.72 ± 0.71 | 10.56 ± 1.70 | 88.13 ± 9.86 | 0.06 ± 0.05 | 0.33 ± 0.10 | 114.57 ± 18.49 | 88.02 ± 10.69 | 0.05 ± 0.09 |
| IDA and IQA | 3.48 ± 0.82 | 9.65 ± 1.27 | 88.14 ± 11.24 | 0.09 ± 0.04 | 0.40 ± 0.10 | 108.58 ± 9.69 | 90.07 ± 10.86 | 0.04 ± 0.03 |
HS hereditary spherocytosis, IDA iron deficiency anemia, IQA anemia of first quarter of life, HA hemolytic anemia, TM thalassemia minor, CKD chronic kidney disease